With the advent of transcatheter mitral valve replacement (TMVR), the concept of the neo–
left ventricular outflow tract (LVOT) was introduced and remains an essential component of …

Transcatheter mitral valve implantation (TMVI) represents a promising approach to treating
mitral valve regurgitation in patients at increased risk of perioperative mortality. Similar to …

Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …

Background: The risk of surgical mitral valve replacement in patients with severe mitral
annular calcification (MAC) is high. Several patients worldwide with severe MAC have been …

Objectives: This study sought to evaluate the outcomes of the early experience of
transcatheter mitral valve replacement (TMVR) with balloon-expandable valves in patients …

As no previous experience with a TMVI procedure in man existed, extracorporeal circulation
support was shortly used during valve deployment (15 minutes) to ensure hemodynamic …

Mitral regurgitation is one of the most common forms of heart valve disorder, which may
result in heart failure. Due to the rapid ageing of the population, surgical repair and …

The emergence of transcatheter aortic valve replacement (TAVR) has segued the
development of transcatheter mitral valve (MV) repair devices. Transcatheter mitral valve …

Transcatheter mitral valve replacement (TMVR) is a catheter-based interventional technique
for treating mitral valve disease in patients who are at high risk for open mitral valve surgery …

Objectives: This study sought to determine late (2-year) outcomes following transcatheter
mitral valve replacement (TMVR) with the FORTIS valve (Edwards Lifesciences, Irvine …